Charles Schwab Investment Management Inc Bridge Bio Pharma, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,282,229 shares of BBIO stock, worth $43.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,282,229
Previous 1,306,765
1.88%
Holding current value
$43.9 Million
Previous $35.9 Million
23.62%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$755 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$660 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$510 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$426 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$246 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.08B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...